Quickly vetted, treatment is offered to patients

RSS

New York Times, October 27, 2008

The Food and Drug Administration allows thousands of medical devices onto the market each year after only cursory review and with no clear evidence that they help patients. Doctors are free to use those products as they see fit, without telling patients that the devices are not proved. And because the doctors are frequently paid more by Medicare as a way to compensate them for the extra time and expense of adopting new procedures, these unproven products can become widely adopted. FDA officials defend the quick-review process as a way to promote innovation.

Full Story

J&J recalls hip replacement implant

More than two years after the Food and Drug Administration began receiving complaints about the failure of a hip replacement implant made by the DePuy Orthopaedics unit of Johnson & Johnson, the...

Medical device makers pan FDA proposals

Proposed changes to the U.S. system for regulating medical devices are more objectionable to the industry than some local experts expected. Late Tuesday, the Food and Drug Administration issued a...

FDA moves toward tighter medical device oversight

Makers of X-ray machines, drug pumps and other medical devices would have to submit more safety information to win federal approval under a proposal designed to tighten regulation of thousands of products...

Webcast: OPPE Best Practices Series: When OPPE leads to FPPE

Join speakers Valerie Handunge, MA, senior healthcare strategy and operations consultant, Deloitte Consulting, and Evalynn Buczkowski, RN, BSN, MS, regional director, clinical performance...

go to complete list